India, June 10 -- Shattuck Labs, Inc. (STTK), a clinical-stage biotechnology company, on Wednesday revealed the pricing of its earlier announced public offering of 10.88 million shares of common stock at $4.00 per share. The company is also offering pre-funded warrants to purchase up to 7.87 million shares at $3.9999 per warrant to certain investors.
The offering is expected to generate gross proceeds of approximately $75 million before underwriting discounts, commissions, and other offering-related expenses. The transaction is expected to close on June 11, subject to customary closing conditions, the company said in an official statement.
Additionally, Shattuck Labs said that it has granted the underwriters a 30-day option to purchase up...